Suppr超能文献

短期大剂量阿托伐他汀对首次发作前壁急性心肌梗死患者左心室重构的影响

Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.

作者信息

Liu Zhi-Jian, Hu Gao-Pin, Fei Mei-Ying, Yin Zao, Shi Quan-Xing, Sun Fei

机构信息

Department of Cardiology, the 210th Hospital of People's Liberation Army, Dalian, Liaoning 116021, China.

Department of Cardiology, the 306th Hospital of People's Liberation Army, Beijing 100101, China.

出版信息

Chin Med Sci J. 2018 Jun 30;33(2):84-90. doi: 10.24920/11810.

Abstract

Objects The aim of this trial was to evaluate the effect of short-term high-dose atorvastatin therapy on levels of high-sensitivity C-reactive protein (hs-CRP), malonaldehyde (MDA), endothelin-1(ET-1), matrix metalloproteinases (MMPs), and left ventricular (LV) remodeling in patients with first time attack of acute anterior myocardial infarction (AAMI) .Methods A hundred and three patients with first time attack of AAMI who underwent successful primary percutaneous coronary intervention were randomized to receive atorvastatin 40 mg once daily for 1 week followed by 20 mg once daily (intensive treatment group, IT group, n=49), or atorvastatin 20 mg once daily (standard treatment group, ST group, n=54). Plasma levels of hs-CRP, MDA, ET-1, MMP-2 and MMP-9 were measured on admission, at 1 week, 2 weeks and 6 months follow up and compared between the IT group and ST group. Echocardiography was performed on admission, at 2 week, and 1 year follow up. The left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV) and left ventricular ejection fraction (LVEF) were measured at each echocardiographic examination and compared between the IT group and ST group.Results Plasma levels of hs-CRP (F=7.718, P=0.009), ET-1 (F=7.882, P=0.006), MMP-9 (F=4.834, P=0.028) and pro-BNP (F=4.603, P=0.032) were significantly lower at 1 week after initial onset of AAMI in the IT group compared with the ST group. The changes of LVEDV, LVESV, and LVEF at the 1 year follow-up from the admission did not differ between the IT group and the ST group (t=0.722, P=0.444; t=1.228, P=0.221; t=1.354, P=0.187, repectively).Conclusions Short-term high-dose atorvastatin treatment for AAMI was associated with lower hs-CRP, ET-1 and MMP-9 levels compared to the standard dose treatment. However, this beneficial effect is not likely to related to the left ventricular remodeling.

摘要

目的 本试验旨在评估短期大剂量阿托伐他汀治疗对首次发作急性前壁心肌梗死(AAMI)患者的高敏C反应蛋白(hs-CRP)、丙二醛(MDA)、内皮素-1(ET-1)、基质金属蛋白酶(MMPs)水平及左心室(LV)重构的影响。方法 103例首次发作AAMI且成功接受直接经皮冠状动脉介入治疗的患者被随机分为两组,一组接受阿托伐他汀40 mg每日1次,共1周,之后20 mg每日1次(强化治疗组,IT组,n = 49),另一组接受阿托伐他汀20 mg每日1次(标准治疗组,ST组,n = 54)。在入院时、1周、2周及6个月随访时测定两组患者血浆hs-CRP、MDA、ET-1、MMP-2和MMP-9水平并进行比较。在入院时、2周及1年随访时进行超声心动图检查。每次超声心动图检查时测量左心室舒张末期容积(LVEDV)、左心室收缩末期容积(LVESV)和左心室射血分数(LVEF),并在两组间进行比较。结果 与ST组相比,IT组在AAMI初次发作后1周时血浆hs-CRP(F = 7.718,P = 0.009)、ET-1(F = 7.882,P = 0.006)、MMP-9(F = 4.834,P = 0.028)和脑钠肽前体(F = 4.603,P = 0.032)水平显著降低。IT组和ST组从入院到1年随访时LVEDV、LVESV和LVEF的变化无差异(分别为t = 0.722,P = 0.444;t = 1.228,P = 0.221;t = 1.354,P = 0.187)。结论 与标准剂量治疗相比,AAMI短期大剂量阿托伐他汀治疗可使hs-CRP、ET-1和MMP-9水平降低。然而,这种有益作用可能与左心室重构无关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验